NFE2L2 is a transcription factor that primarily affects the expression of antioxidant genes and its activation regulates a variety of cancer hallmarks related to EMT, including tumor aggressiveness, invasion, and metastasis formation [36], and has a significant impact in esophageal carcinoma (ESCA) [37]. This evidence concerns the gene NFE2L2 and cancer.